NasdaqGS - Nasdaq Real Time Price USD

Vigil Neuroscience, Inc. (VIGL)

2.3600
+0.0400
+(1.75%)
As of 9:30:06 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
91,737
89,683
88,866
68,884
42,409
Operating Income
-91,737
-89,683
-88,866
-68,884
-42,409
Net Non Operating Interest Income Expense
5,001
5,418
6,241
623
3
Other Income Expense
7
9
-13
-44
-877
Pretax Income
-86,729
-84,256
-82,638
-68,305
-43,283
Net Income Common Stockholders
-86,729
-84,256
-82,638
-68,305
-43,283
Diluted NI Available to Com Stockholders
-86,729
-84,256
-82,638
-68,305
-43,283
Basic EPS
-2.06
--
-2.13
-2.16
-1.53
Diluted EPS
-2.06
--
-2.13
-2.16
-1.53
Basic Average Shares
42,219.3860
--
38,712.2070
31,685.1250
28,263.9630
Diluted Average Shares
42,219.3860
--
38,712.2070
31,685.1250
28,263.9630
Total Operating Income as Reported
-91,737
-89,683
-88,866
-68,884
-42,409
Total Expenses
91,737
89,683
88,866
68,884
42,409
Net Income from Continuing & Discontinued Operation
-86,729
-84,256
-82,638
-68,305
-43,283
Normalized Income
-86,729
-84,256
-82,638
-68,305
-43,283
Interest Income
5,001
5,418
6,241
623
3
Net Interest Income
5,001
5,418
6,241
623
3
EBIT
-91,737
-89,683
-88,866
-68,884
-42,409
EBITDA
-91,273
-89,230
-88,467
-68,806
-42,381
Reconciled Depreciation
464
453
399
78
28
Net Income from Continuing Operation Net Minority Interest
-86,729
-84,256
-82,638
-68,305
-43,283
Normalized EBITDA
-91,273
-89,230
-88,467
-68,806
-42,381
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 1/7/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACRV Acrivon Therapeutics, Inc.
1.1200
+1.82%
 
RAPP Rapport Therapeutics, Inc.
9.76
+0.05%
 
MBX MBX Biosciences, Inc.
10.74
+0.85%
 
RLYB Rallybio Corporation
0.3400
+3.79%
 
ARTV Artiva Biotherapeutics, Inc.
2.1000
-1.41%
 
KYMR Kymera Therapeutics, Inc.
30.00
-0.07%
 
OKUR OnKure Therapeutics, Inc.
2.0501
-0.48%
 
ABOS Acumen Pharmaceuticals, Inc.
1.0000
-0.99%
 
AGIO Agios Pharmaceuticals, Inc.
28.39
+0.46%
 
ALXO ALX Oncology Holdings Inc.
0.4401
+0.99%